By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists agreed that while VXUS inflows signal demand for international diversification, the thesis comes with significant risks such as currency moves, uneven regional growth, regulatory risks, and valuation concerns. The consensus was neutral, with some bearish leanings due to the potential for non-US equities to underperform US equities in the near term.
Risk: Currency moves and uneven regional growth
Opportunity: Diversification benefits in case of US underperformance
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Vanguard Total International Stock Index ETF benefited from the fifth-largest inflow of cash over the year-to-date period.
The ETF provides U.S. investors with something that they may be missing.
Through the first five months of the year, roughly $836 billion of cash has been invested in exchange-traded funds (ETFs). Vanguard Total International Stock Index ETF (NASDAQ: VXUS) was the fifth-largest beneficiary of that cash, but there's an important twist here. Normally, following the crowd is a risky approach, but in this situation, you may want to consider doing it.
Of the cash flowing into ETFs so far in 2026, the three with the largest inflows are all broad-based U.S. equity ETFs, two of which track the S&P 500 index. Number four is a short-term bond ETF, which is basically just a step above cash. Which makes number five, Vanguard Total International Stock Index ETF, stand out.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Most U.S. investors focus heavily on domestic stocks. That makes sense, since these are the companies investors see and know well. However, the U.S. accounts for only around 25% of global gross domestic product (GDP). If all you own are U.S. companies, you are ignoring a material portion of the global economy. To be fair, many U.S. businesses operate internationally. But even that fact will likely leave you underexposed internationally.
Investors looking to quickly and easily add international exposure to their portfolio are clearly choosing to buy Vanguard Total International Stock Index ETF. It is a good choice. For starters, its expense ratio is a very modest 0.05%. That's notable because it is fairly costly to trade stocks internationally, but the size and scale Vanguard offers help to keep the costs low. The ETF has more than $600 billion in assets.
But the other big story here is that Vanguard Total International Stock Index ETF provides instant international diversification. It basically buys all investable non-U.S. stocks using a market-cap-weighted approach. With a single purchase, you will be adding exposure to all of the most important stocks the world has to offer.
Investors often end up with undiversified portfolios because they don't pay enough attention to diversification. It is actually pretty normal for this to happen because investing in a broad basket of stocks to create a diversified portfolio materially increases complexity. Vanguard Total International Stock Index ETF lets you materially expand your investment universe, thereby increasing diversification, without adding significant complexity. That's likely a big reason for the huge cash inflows to the ETF and why you may want to follow the crowd this time around.
Before you buy stock in Vanguard Total International Stock ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard Total International Stock ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 7, 2026. *
Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Diversification via VXUS is useful, but the crowd signal is not a free lunch; currency and macro risk can erase near-term upside."
Two takeaways: VXUS inflows show demand for international diversification as a hedge against US-guided markets. But the article glosses over key risks that could derail the thesis: currency moves (VXUS trades in USD but underlying exposures aren’t currency-hedged), uneven regional growth and regulatory risk, and valuations that are not uniformly cheap. A stronger US growth path or higher rate differentials could leave non-US equities underperforming for years. Diversification is valuable, but following the crowd into VXUS is not a free lunch; FX and macro risks can erase any near-term upside.
FX and macro risks could wipe out gains even if flows persist. If the US maintains a rate advantage or dollar firming, international equities could underperform despite inflows.
"Increased inflows into VXUS reflect a defensive move to mitigate U.S. concentration risk rather than a tactical bet on superior international growth."
The inflow into VXUS signals a long-overdue rotation out of U.S. mega-cap concentration, but investors should be wary of the 'diversification' trap. While VXUS offers a 0.05% expense ratio and broad exposure, it is heavily tilted toward developed markets like Japan and the UK, which have historically struggled with structural stagnation and lower innovation premiums compared to the U.S. tech sector. Simply buying the global market cap ignores the 'quality' factor; you are buying the world's laggards alongside its leaders. If the U.S. dollar weakens, international stocks will provide a necessary hedge, but this is a tactical currency play, not a fundamental growth strategy.
The case against this is that international markets have consistently lagged the S&P 500 for over a decade due to lower return on invested capital (ROIC) and a lack of exposure to the AI-driven productivity boom.
"VXUS inflows are mechanical rebalancing, not a signal of value; developed ex-US underperformance since 2015 is the real story the article buries."
VXUS inflows reflect rational rebalancing, not conviction. The article conflates 'money flowing in' with 'good investment timing'—but $836B into ETFs YTD is mostly passive rebalancing and 401(k) contributions, not tactical positioning. More concerning: developed ex-US (VXUS's core) has lagged the S&P 500 by ~400bps annually since 2015. The 25% GDP argument ignores that U.S. large-caps already capture most global growth. The article also omits currency headwinds, emerging market concentration risks (Taiwan, China), and that VXUS's 0.05% fee advantage evaporates if international underperformance persists. Diversification is valid; the framing that crowds are right 'this time' is marketing.
If U.S. exceptionalism is finally exhausted and mean reversion hits—international at 12x forward P/E vs. U.S. at 20x+ could deliver 5-7 years of outperformance that dwarfs fee savings. The crowd may be early, not wrong.
"Diversification benefits of VXUS are real but do not override the persistent US earnings-growth premium that has justified home bias."
VXUS inflows of roughly $836B YTD context signal rising recognition that US investors remain underweight non-US equities representing 75% of global GDP. The 0.05% expense ratio and market-cap diversification across developed and emerging markets reduce single-country risk effectively. Yet the article downplays that VXUS has trailed S&P 500 by wide margins for 15 years due to slower earnings growth outside the US, ongoing China regulatory overhang, and eurozone stagnation. Currency translation and higher trading frictions could still erode net returns even at Vanguard scale.
Mean-reversion in valuations could deliver outsized VXUS gains if US multiples compress and international earnings finally accelerate, making the long underperformance a contrarian entry signal rather than a warning.
"Mean reversion in valuations is not a reliable path to 5–7 years of VXUS upside; currency, growth, and regulatory headwinds could keep non-US equities underperforming longer than a typical cycle."
Responding to Grok: I’d push back on the idea that mean reversion guarantees 5–7 years of VXUS upside from a US multiple compress. Even if US multiples shrink, VXUS’s tailwinds depend on synchronized earnings growth and currency stability, which remains uncertain. USD strength, China/regulatory risk, and eurozone stagnation could keep international equities mired longer than a typical cycle, meaning asymmetric risk to the downside if the re-rating never arrives.
"VXUS exposure is a structural bet on low-growth, legacy-heavy economies that lack the innovation premium necessary to outperform the U.S."
Claude is right about passive flows, but everyone is ignoring the 'zombie' index effect. VXUS isn't just a geographical bet; it is a structural bet on low-growth, legacy-heavy economies. By buying this, you are effectively shorting the global 'innovation premium' that the U.S. currently monopolizes. Unless you believe the EU or Japan will suddenly pivot to high-ROIC tech dominance, this diversification is just buying a lower-growth anchor for your portfolio, regardless of valuation multiples.
"VXUS's case rests on valuation mean reversion and yield, not on Europe/Japan suddenly winning the innovation race."
Gemini's 'zombie index' framing conflates valuation with growth potential—but it ignores that VXUS holds ~40% in Japan, UK, Switzerland: developed markets with stable cash flows and 2-3% dividend yields, not growth laggards. The real issue isn't innovation premium; it's whether 12x forward P/E on 5-6% earnings yields justifies underweight vs. 20x+ US multiples. That's a math question, not an ideology question. If US rates stay elevated, the yield gap persists regardless of tech dominance.
"VXUS's developed holdings offer a hedge via yields if US AI momentum falters, countering the low-growth dismissal."
Gemini overlooks how Claude's yield math interacts with unmentioned macro risks: at 5-6% earnings yields in stable developed markets like Japan and UK, VXUS could buffer against US tech concentration if AI productivity gains stall or rates diverge further. This isn't about sudden innovation pivots but relative return compression that diversification captures.
The panelists agreed that while VXUS inflows signal demand for international diversification, the thesis comes with significant risks such as currency moves, uneven regional growth, regulatory risks, and valuation concerns. The consensus was neutral, with some bearish leanings due to the potential for non-US equities to underperform US equities in the near term.
Diversification benefits in case of US underperformance
Currency moves and uneven regional growth